Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Kering | PPXB | 27. nov 2024 | 22.60 | +3.67 |
Kering SA | PPX | 27. nov 2024 | 225.40 | +2.36 |
Kerlink | 344 | 27. nov 2024 | 0.51 | +2.63 |
Kernel Holding SA | 0KE | 27. nov 2024 | 3.21 | +5.41 |
Kerry Group Plc | KRZA | 27. nov 2024 | 88.00 | +1.15 |
Kerry Group Plc | KRZ | 27. nov 2024 | 89.60 | -0.33 |
KERRY LOG NET | KYL | 27. nov 2024 | 0.89 | +7.88 |
KERRY PPT | KR3 | 27. nov 2024 | 1.81 | 0.00 |
KESKO A | KEK1 | 27. nov 2024 | 18.78 | +0.43 |
Kesko B | KEK | 27. nov 2024 | 18.98 | -0.08 |
Kesselrun Resources Ltd | CMG | 27. nov 2024 | 0.02 | +16.67 |
Keurig Dr Pepper Inc. | DP5 | 27. nov 2024 | 30.68 | -1.32 |
Kewaunee Scientific | KEW | 27. nov 2024 | 40.20 | 0.00 |
Kewpie Corporation | QPJ | 27. nov 2024 | 21.00 | +1.94 |
Key Tronic Corporation | KT1 | 27. nov 2024 | 5.15 | +1.98 |
KeyCorp | KEY | 27. nov 2024 | 18.59 | -0.75 |
Keyence Corporation | KEE | 27. nov 2024 | 398.30 | -0.95 |
Keyera Corp | K2Y | 27. nov 2024 | 31.02 | +0.71 |
Keymed Biosciences Inc. | 64Z | 27. nov 2024 | 4.84 | +2.11 |
Keyrus Progiware | 5UP | 27. nov 2024 | 7.54 | -0.53 |
Keysight Technologies Inc | 1KT | 27. nov 2024 | 164.04 | +0.69 |
Keyware Technologies NV | KY3A | 27. nov 2024 | 0.73 | -2.00 |
Kezar Life Sciences, Inc. | 2KZ | 27. nov 2024 | 6.95 | 0.00 |
Kforce, Inc. | ROF | 27. nov 2024 | 55.50 | 0.00 |
KGHM Polska Miedz S.A. | KGHA | 27. nov 2024 | 28.82 | -4.19 |
KGL Resources Limited | KN6 | 27. nov 2024 | 0.05 | +2.04 |
KHD Humboldt Wedag International AG | KWG | 27. nov 2024 | 1.51 | -3.21 |
Kiatnakin Phatra Bank Public Company Ltd | KIFF | 27. nov 2024 | 1.36 | 0.00 |
Kid | 97Q | 27. nov 2024 | 10.34 | -0.77 |
Kier Group PLC | 10I | 27. nov 2024 | 1.71 | -1.72 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.